<DOC>
	<DOC>NCT00601419</DOC>
	<brief_summary>Post marketing drug use investigation of Genotropin for GHD-ADULTS.</brief_summary>
	<brief_title>Drug Use Investigation of Somatropin for GHD-ADULTS.</brief_title>
	<detailed_description>All the patients whom an investigator prescribes the first Somatropin should be registered consecutively until the number of subjects reaches target number.</detailed_description>
	<mesh_term>Dwarfism, Pituitary</mesh_term>
	<mesh_term>Dwarfism</mesh_term>
	<criteria>The patients who were administered Somatropin to treat "Adult growth hormone deficiency (limited to severe type)". Patients not administered Somatropin.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>